F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

Jason D. Oliver, Graham E.M. Sibley, Nicola Beckmann, Katharine S. Dobb, Martin J. Slater, Laura McEntee, Saskia Du Pré, Joanne Livermore, Michael J. Bromley, Nathan P. Wiederhold, William W. Hope, Anthony J. Kennedy, Derek Law, Mike Birch

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase'. Together they form a unique fingerprint.

Medicine & Life Sciences